Prkca — Protein Kinase C Alpha plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
| Gene Symbol | PRKCA |
| Full Name | Protein Kinase C Alpha |
| Chromosome | 17q24.2 |
| NCBI Gene ID | 5578 |
| OMIM | 176960 |
| Ensembl ID | ENSG00000154229 |
| UniProt ID | P17252 |
| Associated Diseases | Alzheimer's Disease, Schizophrenia |
Protein Kinase C alpha (PKCα), encoded by the PRKCA gene, is a member of the protein kinase C family of serine/threonine kinases. PKCα is a conventional isoform that requires diacylglycerol (DAG), calcium, and phosphatidylserine for full activation. This enzyme plays crucial roles in various cellular signaling pathways that regulate proliferation, differentiation, apoptosis, and synaptic plasticity.
PKCα is particularly important in the nervous system, where it participates in synaptic transmission, long-term potentiation (LTP), and memory formation. The enzyme is widely expressed throughout the brain, with particularly high levels in the hippocampus, cortex, and cerebellum. Dysregulation of PKCα signaling has been implicated in several neurodegenerative and psychiatric disorders, including Alzheimer's disease and schizophrenia.
PRKCA encodes the alpha isoform of protein kinase C (PKCα), a serine/threonine kinase that is activated by diacylglycerol (DAG), calcium, and phosphatidylserine. PKCα is a conventional PKC isoform involved in various cellular processes including cell proliferation, differentiation, apoptosis, and synaptic plasticity.
In neurons, PKCα plays important roles in synaptic transmission, long-term potentiation (LTP), and memory formation. It phosphorylates various synaptic proteins including NMDA receptor subunits, AMPA receptor regulatory proteins, and ion channels.
Widely expressed in the brain with high levels in the hippocampus, cortex, and cerebellum. PKCα is localized to both pre-synaptic and post-synaptic compartments.
| Disease | Mechanism |
|---|---|
| Alzheimer's Disease | Dysregulated PKC signaling, impaired synaptic plasticity |
| Schizophrenia | Altered PKC-dependent signaling pathways |
PKC modulators are being explored for treating AD and cognitive disorders. PKC activators have shown promise in improving memory in animal models.
Prkca — Protein Kinase C Alpha plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Prkca — Protein Kinase C Alpha has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.